QuidelOrtho Q2 supplemental combined revenue $898.5M, adj EPS $2.12, up 123% YoY

QuidelOrtho Corp

2022-Q2 EPS reported $10.47 revenue$1,615,700,000

GAAP revenue $613.4M (+247% as reported) from business combination with Ortho closed May 27, 2022.
Supplemental combined revenue $898.5M (+37.5% constant currency); excluding COVID-19 revenue, growth 9.0%.
GAAP diluted EPS $0.36 vs $0.45 prior year; supplemental adjusted EPS $2.12 vs $0.95 (+123%).
Adjusted EBITDA $290.8M, margin 32.4% vs 24.8% prior year; strong double-digit growth in POC and Molecular Diagnostics.
Foreign currency negatively impacted sales growth by ~320 bps. No formal 2022 guidance provided in release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.